Vimta Labs P/E Ratio

Current P/E Ratio
28.1
High Valuation
High - Growth expectations or overvalued

Vimta Labs P/E ratio. Vimta Labs (VIMTALABS) P/E ratio is 28.1 (High), EPS (TTM) ₹18.51, current price ₹471.95 on NSE vs historical average P/E of 8.62 (100.0th percentile) — High - Growth expectations or overvalued. Also explore VIMTALABS share price charts to track price trends across different timeframes.

Current Valuation Metrics

P/E Ratio 28.1
Current Price ₹471.95
EPS (TTM) ₹18.51
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 8.62
Historical Range 5.16 - 12.24
Percentile 100.0%

Sector Context

Sector Average 52.29
Sector Median 29.6
Sector Rank #11 of 255
Sector Percentile 4.3%

Earnings Breakdown (TTM)

TTM EPS ₹27.65
Sept 2024 ₹6.88
Mar 2024 ₹5.58

VIMTALABS P/E Ratio — Valuation Signal & Historical Context

Vimta Labs P/E 28.1 vs historical average 8.62, range 5.16–12.24 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see VIMTALABS stock price BSE.

  • Stock appears overvalued with PE of 28.1, suggesting caution for new investments
  • Current PE is 225.9% above historical average
  • Trading at discount to sector average PE of 52.29

Vimta Labs P/E Ratio Historical Trend

VIMTALABS annual price-to-earnings ratio — 4 years, EPS and year-end price. Current P/E 28.1 vs historical average 8.62. Check Vimta Labs networth to track the company's total market size over time.

VIMTALABS Historical P/E Ratio — EPS, Year-End Price & Valuation

Vimta Labs annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2024 7.33 27.65 ₹202.65 NSE Low
2023 12.24 17.71 ₹216.85 NSE Low
2022 9.76 21.4 ₹208.85 NSE Low
2021 5.16 16.84 ₹86.95 NSE Low

VIMTALABS vs Healthcare Peers — P/E Ratio Comparison

Vimta Labs P/E 28.1 vs Healthcare average 52.29, median 29.6 — range 2.0–733.0.

Sector Average
52.29
Sector Median
29.6
Lowest P/E
2.0
Highest P/E
733.0
Companies
255
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.0 ₹72 Low
Brooks Laboratories BROOKS 2.6 ₹206 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.3 ₹54 Low
Sun Pharma Advanced Rese… SPARC 4.1 ₹6,355 Low
Dipna Pharmachem DPL 4.5 ₹11 Low
JFL Life Sciences JFLLIFE 4.7 ₹82 Low
Royal Sense ROYAL 4.8 ₹34 Low
Star Imaging And Path Lab STARIMAGIN 5.3 ₹110 Low
Kabra Drugs KABRADG 6.3 ₹49 Low